Renal Osteodystrophy

Slide 1 · Renal Osteodystrophy

Bone remodeling, mineralization, and renal endocrine dysfunction

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define

State the skeletal scope of renal osteodystrophy.

Explain

Trace kidney–bone endocrine and acid–base disruptions.

Recognize

Distinguish high-, low-, and mixed-turnover lesions.

Apply

Relate bone pathology to fractures and impaired growth.

Slide 3 · Renal osteodystrophy: A skeletal spectrum

Collective skeletal changes associated with chronic renal disease.

Includes skeletal disease occurring in patients receiving dialysis.

Represents multiple overlapping abnormalities, not one histologic lesion.

Conceptual scope

Chronic renal disease

Altered mineral / endocrine balance

Abnormal skeletal remodeling

Slide 4 · Why the skeleton is affected in chronic kidney disease

Loss of renal excretory and endocrine functions

Disturbed phosphate, calcium, vitamin D, and acid–base balance

Altered PTH signaling and osteoclast/osteoblast behavior

Bone loss, defective mineralization, or abnormal turnover

Slide 5 · Four skeletal manifestations

Osteopenia / osteoporosis

Decreased quantity of normally mineralized bone.

Osteomalacia

Insufficient mineralization of bone matrix.

Secondary hyperparathyroidism

PTH-associated increase in skeletal resorption.

Growth retardation

Skeletal consequences in immature patients.

Slide 6 · One syndrome, several distinct bone abnormalities

Bone quantity

How much bone is present?

Bone turnover

How active are resorption and formation?

Mineralization

How effectively is osteoid calcified?

A patient can have disturbances on more than one axis.

Slide 7 · Bone remodeling is a coupled process

Osteoclasts attach to bone and resorb matrix

Osteoblasts populate the resorbed surface

Osteoblasts synthesize osteoid

Matrix mineralization restores mature bone

Slide 8 · Osteoblasts form the organic bone matrix

Osteoblasts are responsible for synthesizing new osteoid.

Bone formation follows resorption during normal remodeling.

PTH and local signaling alter osteoblast communication with osteoclasts.

Functional link

Osteoblast

Osteoid deposition

Subsequent mineralization

Slide 9 · Osteoclasts remove mineralized matrix

Multinucleated osteoclasts arise from monocyte-lineage cells.

Attachment creates a sealed resorption compartment.

Acid and proteolytic enzymes dissolve inorganic and organic bone.

Functional link

Osteoclast attachment

Resorption pit

Matrix loss

Slide 10 · Osteocytes couple bone to mineral homeostasis

Osteocytes are embedded within bone matrix.

They detect mechanical forces and regulate local remodeling.

Osteocytes as the source of FGF-23.

Bone–kidney link

Osteocyte

FGF-23 secretion

Renal phosphate handling

Slide 11 · RANKL stimulates osteoclast differentiation

RANKL expressed by osteoblasts / stromal cells

RANK on osteoclast precursors

NF-κB–dependent osteoclast differentiation

Increased bone resorption

Slide 12 · Osteoprotegerin restrains the RANKL signal

RANKL–RANK interaction

Supports osteoclast differentiation

Promotes osteoclastic resorption

OPG binding RANKL

OPG acts as a soluble decoy receptor

Blocks RANKL access to RANK

Slide 13 · Parathyroid hormone acts indirectly on osteoclasts

PTH signaling to osteoblast lineage

Increased osteoblast/stromal RANKL

Enhanced differentiation of osteoclasts

Bone resorption and calcium mobilization

Slide 14 · The kidney controls active vitamin D production

Renal synthesis of 1,25(OH)₂ vitamin D

Increased intestinal calcium absorption

Support of calcium homeostasis

Availability of calcium for matrix mineralization

Slide 15 · Normal phosphaturic signaling involves FGF-23

FGF-23 released by osteocytes

Renal response involves Klotho

Promotion of urinary phosphate excretion

Regulation of phosphate balance

Slide 16 · Normal renal–bone communication has two arms

Phosphate arm

Osteocyte-derived FGF-23

Renal Klotho-dependent response

Urinary phosphate elimination

Calcium / vitamin D arm

Renal active vitamin D production

Intestinal calcium absorption

PTH feedback and bone response

Slide 17 · Chronic renal dysfunction disrupts both arms

Renal dysfunction

Phosphate retention and reduced active vitamin D

Hyperphosphatemia and impaired calcium absorption

Secondary hyperparathyroidism and impaired mineralization

Slide 18 · Reduced phosphate excretion promotes retention

Hypophosphaturia means insufficient urinary phosphate elimination.

Impaired renal handling contributes to hyperphosphatemia.

Phosphate retention upstream of secondary hyperparathyroidism.

Cause → consequence

Reduced phosphaturia

Phosphate retention

↑ Serum phosphate

Slide 19 · Klotho supports renal responsiveness to FGF-23

Klotho participates in the renal response to osteocyte-derived FGF-23.

In renal disease, reduced Klotho expression weakens this signaling arm.

Phosphate retention persists despite the normal phosphaturic role of FGF-23.

Disrupted signal

↓ Renal Klotho

Impaired FGF-23 action

↓ Phosphate excretion

Slide 20 · FGF-23 is a bone-derived endocrine signal

Osteocyte

FGF-23

Kidney with Klotho-dependent signaling

Urinary phosphate excretion

Slide 21 · Impaired FGF-23–Klotho signaling matters because...

Bone normally communicates its phosphate status to the kidney.

Renal Klotho reduction compromises phosphaturic signaling.

The defect couples progressive kidney dysfunction to skeletal disease.

Mechanistic point

Bone-to-kidney signal

Reduced renal response

Systemic phosphate imbalance

Slide 22 · Renal vitamin D synthesis declines

Progressive impairment of renal function

Reduced 1,25(OH)₂ vitamin D synthesis

Less intestinal calcium absorption

Reduced substrate for bone matrix calcification

Slide 23 · Diminished intestinal calcium absorption

Active vitamin D normally increases dietary calcium absorption.

Less active vitamin D reduces intestinal calcium uptake.

Hypocalcemia contributes to secondary PTH elevation.

Endocrine cascade

↓ Active vitamin D

↓ Gut Ca²⁺ absorption

Hypocalcemic drive

Slide 24 · Hypocalcemia drives compensatory PTH secretion

Reduced gut calcium absorption

Hypocalcemia

Increased parathyroid stimulation

Secondary hyperparathyroidism

Slide 25 · Secondary hyperparathyroidism is a renal response

The stimulus arises from renal phosphate and calcium imbalance.

Parathyroid activity increases as a secondary consequence.

Persistent PTH excess promotes osteoclast-driven skeletal remodeling.

Distinguishing feature

Renal dysfunction

Biochemical stimulus

Secondary PTH increase

Slide 26 · Why phosphate and calcium mechanisms converge

Pathway A

Reduced phosphate excretion

Hyperphosphatemia

Pathway B

Reduced active vitamin D

Reduced calcium absorption

Both pathways contribute to secondary hyperparathyroidism.

Slide 27 · Tubular dysfunction causes systemic acidosis

Renal tubular dysfunction

Tubular and systemic acidosis

Altered osteoblast RANKL expression

Greater osteoclast-mediated resorption

Slide 28 · Acidosis activates the osteoclast pathway

Acidosis increases RANKL expression on osteoblasts.

RANKL promotes differentiation and function of osteoclasts.

Increased resorption produces loss of bone matrix.

Named mediator

Acidosis

↑ RANKL

↑ Osteoclast activity

Slide 29 · Osteopenia is a quantitative bone deficit

Normal bone quantity

More preserved trabecular architecture

Normal amount of mineralized matrix

Osteopenia / osteoporosis

Reduced total skeletal bone mass

Residual matrix may be normally mineralized

Slide 30 · Osteoporosis and osteomalacia are not synonyms

Osteoporosis

Reduced amount of bone

Mineralization of remaining bone is normal

Fragility follows reduced structural mass

Osteomalacia

Insufficient mineralization of osteoid

Bone formed during remodeling remains undermineralized

Mechanical weakness despite a different defect

Slide 31 · Three histologic patterns in end-stage renal failure

High turnover

Resorption and formation increased

Resorption predominates

Low turnover

Adynamic bone: Both cell activities low

Osteomalacia occurs less commonly

Mixed

High- and low-turnover areas

Heterogeneous skeletal pattern

Slide 32 · Turnover describes the pace of remodeling

High turnover

Both formation and resorption increased.

Low turnover

Osteoblast and osteoclast activity reduced.

Mixed turnover

Different regions exhibit different patterns.

Turnover is not interchangeable with mineralization or bone mass.

Slide 33 · High-turnover osteodystrophy: Resorption dominates

Secondary hyperparathyroidism / resorptive stimuli

Higher osteoclast activity

Higher coupled osteoblast activity

Net resorption exceeds bone formation

Slide 34 · High turnover does not mean bone gain

Cellular activity

Formation increases

Resorption increases

Net skeletal balance

Resorption predominates

Progressive reduction of structural bone may occur

Slide 35 · High PTH favors cortical surface resorption

Hyperparathyroidism enhances osteoclast activity.

Subperiosteal and endosteal cortical surfaces are prominently affected.

The process can extend into cancellous bone.

Morphologic distribution

Periosteal surface

Cortical bone

Endosteal surface

Slide 36 · Trabecular tunneling creates dissecting osteitis

Resorptive channels

Bone trabecula

Simplified conceptual schematic — not a tissue section

Osteoclasts may tunnel along the interior of trabeculae.

Adjacent marrow spaces can be replaced by fibrovascular tissue.

The resulting “railroad track” appearance is called dissecting osteitis.

Slide 37 · Dissecting osteitis is not inflammatory osteitis

Descriptive histology term

Longitudinal osteoclastic tunneling

Railroad track-like trabecular pattern

Not implied by the name

It is not primarily an inflammatory process

The lesion reflects excessive resorption

Slide 38 · Fibrovascular tissue follows trabecular resorption

Intense osteoclastic resorption

Disturbance of trabecular architecture

Fibrovascular marrow-space replacement

Peritrabecular fibrous change

Slide 39 · Brown tumors reflect repair after skeletal damage

Bone loss and microfractures

Secondary hemorrhage

Macrophages and fibrovascular repair

Expansile hemorrhagic “brown tumor”

Slide 40 · The term “brown tumor” is morphologic

Brown pigmentation reflects hemorrhage and hemosiderin.

The mass contains a reparative fibrovascular response.

It is not a true neoplasm despite its tumor-like presentation.

Mechanistic triad

Hemorrhage

Hemosiderin

Reparative fibrous tissue

Slide 41 · Severe PTH-mediated bone disease: Osteitis fibrosa cystica

Characterized by increased bone cell activity and peritrabecular fibrosis.

Cystic brown tumors may accompany severe disease.

These findings in hyperparathyroidism; Secondary cases are usually milder.

Composite lesion

Resorption

Fibrosis

Cystic hemorrhagic lesions

Slide 42 · Low-turnover osteodystrophy includes adynamic bone

Osteoclast compartment

Little resorptive activity

Reduced initiation of remodeling units

Osteoblast compartment

Little bone-forming activity

Reduced formation following resorption

Slide 43 · Adynamic bone is a low-cell-activity state

Low osteoclastic activity

Little active resorption

Low osteoblastic activity

Little new bone formation

Slide 44 · Osteomalacia: Impaired calcification of osteoid

Mineralized core

Osteoid

Osteoid

Simplified conceptual schematic — not a tissue section

Matrix produced during bone formation remains insufficiently mineralized.

Reduced active vitamin D and calcium availability contribute.

Defective mineralization differs fundamentally from loss of bone quantity.

Slide 45 · The vitamin D defect links CKD to osteomalacia

Loss of renal active vitamin D synthesis

Reduced intestinal calcium absorption

Insufficient matrix calcification

Osteomalacia

Slide 46 · Low turnover and osteomalacia are distinct features

Adynamic bone

Low osteoclast and osteoblast activity

Turnover defect is the defining feature

Osteomalacia

Defective mineralization

Can be grouped among low-turnover lesions

Slide 47 · Mixed-pattern disease is regionally heterogeneous

Region A

Higher remodeling activity

Prominent resorption

Region B

Lower remodeling activity

Relative cellular quiescence

Overall classification

Both present in the skeleton

Not a uniform turnover state

Slide 48 · Compare the three renal bone patterns

Pattern

Resorption

Formation

Signature

High turnover

Increased

Increased

Resorption predominates

Adynamic / low turnover

Minimal

Minimal

Low bone-cell activity

Mixed

Variable

Variable

High + low turnover areas

Slide 49 · Bone turnover and mineralization require separate questions

Turnover

What are osteoblasts and osteoclasts doing?

Mineralization

Is newly deposited osteoid calcifying?

Quantity

How much structural bone remains?

A single clinical label does not describe all three processes.

Slide 50 · CKD skeletal injury affects growing bone differently

Chronic renal disease in an immature skeleton

Disturbed mineral and endocrine homeostasis

Interference with normal skeletal growth

Growth retardation

Slide 51 · In adults, bone loss predisposes to fracture

Chronic PTH / acid–base / mineral disturbances

Resorption and/or defective mineralization

Reduced structural competence

Greater vulnerability to fractures

Slide 52 · Deformation and joint problems are clinical sequelae

As bone mass falls, mechanical support is reduced.

Weak or abnormal bone can deform under habitual loads.

Skeletal deterioration to fractures, deformation, and joint problems.

Clinicopathologic chain

Abnormal bone structure

Reduced mechanical integrity

Skeletal symptoms

Slide 53 · Renal osteodystrophy vs primary hyperparathyroidism

Primary hyperparathyroidism

Autonomous or inappropriate PTH secretion

Bone changes principally related to PTH excess

Renal osteodystrophy

Renal mineral and endocrine dysfunction

PTH excess plus acidosis and vitamin D deficiency

Slide 54 · Renal osteodystrophy vs isolated osteoporosis

Isolated osteoporosis

Reduced bone quantity

Remaining bone normally mineralized

Renal osteodystrophy

May include osteopenia/osteoporosis

Also includes mineralization and turnover abnormalities

Slide 55 · Renal osteodystrophy vs osteomalacia

Osteomalacia

A specific mineralization defect

Unmineralized matrix contributes to weakness

Renal osteodystrophy

Broad CKD-associated skeletal syndrome

Osteomalacia is one possible component

Slide 56 · Renal osteodystrophy vs Paget disease

Renal osteodystrophy

Driven by chronic renal disease

Metabolic / hormonal pathways are central

Paget disease

Disordered focal bone remodeling

Distinct triphasic histologic evolution

Slide 57 · Integrated pathway: Renal function to skeletal loss

Pathway A

Tubular dysfunction

Systemic acidosis

↑ Osteoblast RANKL

Pathway B

Phosphate retention + ↓ vitamin D

Secondary hyperparathyroidism

↑ PTH-driven RANKL

Increased osteoclastic resorption → osteopenia

Slide 58 · Integrated pathway: Renal function to osteomalacia

Loss of renal active vitamin D synthesis

Reduced intestinal calcium absorption

Diminished calcification of bone matrix

Osteomalacia

Slide 59 · Application 1: Identify a high-turnover mechanism

A teaching vignette describes chronic renal disease, secondary hyperparathyroidism, and bone with strongly increased resorption plus increased formation.

Which turnover category fits best?

Why can bone mass still decline despite increased formation?

Slide 60 · Application 1: Mechanism-based resolution

Classify the pattern as high-turnover osteodystrophy.

Both osteoclastic and osteoblastic activities are increased.

Net resorption exceeds formation, allowing progressive skeletal loss.

Reasoning sequence

↑ PTH / RANKL

↑ Resorption

Bone loss

Slide 61 · Application 2: Recognize low-turnover disease

A conceptual bone-biopsy description in end-stage renal failure reports very little osteoclastic or osteoblastic activity.

What histologic pattern is represented?

Which two cell types define this classification?

Slide 62 · Application 2: Distinguish adynamic bone

The defining pattern is low-turnover (adynamic) bone.

Both osteoclast and osteoblast activities are minimal.

This classification is based on cell activity rather than on PTH alone.

Classification cue

Few active osteoclasts

Few active osteoblasts

Adynamic bone

Slide 63 · Application 3: Interpret mixed renal bone disease

A teaching schematic of bone from chronic renal disease shows one region with high remodeling activity and another with low remodeling activity.

Does a single uniform turnover label capture this?

Which Robbins category accommodates heterogeneity?

Slide 64 · Application 3: Recognize the mixed pattern

Classify regional high- and low-turnover coexistence as mixed-pattern disease.

The defining feature is histologic heterogeneity.

Do not assume that every region of bone has the same turnover state.

Interpretive cue

High-turnover zone

Low-turnover zone

Mixed pattern

Slide 65 · Mechanisms and patterns: Final synthesis

Phosphate

Poor excretion contributes to hyperphosphatemia.

Vitamin D

Deficient activation reduces gut calcium absorption.

PTH + acidosis

These promote RANKL-mediated osteoclastic resorption.

Bone response

High, low, and mixed histologic patterns can result.

Slide 66 · References and source boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 26, pp. 1064–1073.

Chapter 20, pp. 814–815: renal physiology and CKD manifestations.

Figures 26.4, 26.5, 26.10, and 26.11 informed original conceptual schematics; no textbook figures were reproduced.

Mechanism diagrams and vignettes are educational schematics, not histologic specimens or original patient data.